A long wavelength infrared laser system is disclosed where radiation from laser sources such as frequency-doubled Nd:YAG or a Cr:LiSAF is used to resonantly pump a gain medium consisting of a holmium-doped fluoride crystal having a high active ion concentration. The laser pump source has a pulse duration that may be short enough to gain switch a particular transition or long enough to allow end-pumping with high energy densities without damage. The gain material has an absorption approximately resonant with the pump source wavelength, and the dopant concentration is selected to maximize absorption strength for a given excitation. The output radiation from the laser system consists of one or more wavelengths including, in particular 3.9 nm but also other infrared wavelengths such as 1.4 μm, 2.9 μm and 3.4 μm., several of which may be produced simultaneousely from the same laser material through the mechanism of cascade transitions.
|
1. A laser source for generating at least one infrared wavelength, comprising in combination:
a pump source having a wavelength and a peak power density that overcomes a threshold of a selected laser transition; means for coupling radiation from the pump source into a laser cavity; a gain material of holmium-doped fluoride within the laser cavity having an adjustable dopant concentration of holmium to maximize absorption of the pump source wavelength; and optic means for generating at least one wavelength between approximately 1.4 μm and approximately 4 μm from said source.
2. The laser source of
3. The laser source of
approximately 1.4 μm and approximately 3.9 μm.
4. The laser source of
approximately 2.9 μm and approximately 3.9 μm.
5. The laser source of
greater than 2 up to to approximately 10 atomic percent holmium.
6. The laser source of
approximately 10 to approximately 20 atomic percent holmium.
7. The laser source of
greater than approximately 20 atomic percent holmium.
8. The laser source of
a narrow band source emitting at approximately 532 nm.
10. The laser source of
a narrow band source emitting at approximately 890 nm.
13. The laser source of
a diode laser and a diode laser array.
14. The laser source of
a narrow band source emitting at approximately 1.2 microns.
16. The laser source of
17. The laser source of
18. The laser source of
19. The laser source of
20. The gain material of
|
This invention is a division of Ser. No. 09/577,388, filed May 25, 2000, now U.S. Pat. No. 6,269,108, and claims priority based on U.S. Provisional Application Ser. No. 60/135,977 filed May 26, 1999.
This invention relates to solid state lasers, and in particular to a method and apparatus of generating at room temperature one or more wavelengths in the infrared part of the spectrum using high concentration Holmium-doped fluoride crystals to maximize resonant pump absorption.
It is well known that the trivalent holmium ion (Ho3+) is capable of producing stimulated emission at several different wavelengths across the infrared, from 0.75 to just under 4.0 μm. For the purpose of generating longer wavelengths, fluoride crystals are a preferred host for the holmium ion because the energy levels are spaced sufficiently apart within the different manifolds to mitigate against rapid multiphonon non-radiative transitions which would otherwise inhibit fluorescence at wavelengths longer than about 3 μm. Thus, while the Ho transition near 2.9 μm has been made to lase in many different crystals including oxides and garnets, only fluorides exhibited stimulated emission beyond 3 μm. It is further known that because of the rich energy level structure of Ho, a multiplicity of wavelengths can be generated through sequential transitions between intermediate levels.
One of the most interesting Ho transitions is the one near 4 μm between the 5I6 and 5I5 levels. There are very few active ion-host crystal combinations that have been successfully lased this far into the infrared, and none that have demonstrated operation levels substantially greater than a few millijoules at or near room temperature. As will be described below, stimulated emission at 3.9 μm was previously achieved by Ho:YLF but under conditions that severely limit prospects for further energy and power scaling to levels that are of interest.
The main issue limiting laser action at 3.9 μm in Ho-doped crystals, including most known fluorides, is the long fluorescence lifetime of the lower 5I6 laser level coupled with the self-terminating nature of the 5I5→5I6 transition. The long 5I6 lifetime--up to a few milliseconds for most fluoride materials--limits the repetition rate of the corresponding laser transition, whereas the much shorter lifetime of the upper 5I5 level--typically, no more than a few 10's of microseconds, results in an effective three-level system for the laser transition. While it is known in the art that cooling of a three level laser medium can be used to more easily achieve and sustain inversion, this approach is generally considered unattractive for practical laser systems because of added complexity and weight. It has further been recognized that an alternative way to overcome an unfavorable lifetime ratio is through use of resonant pumping, whereby the upper laser level is directly excited by a narrow band source with frequency selected or tuned to match an absorption line that is dynamically connected to the upper level of the desired transition. When the resonant pump source also has a very short pulse duration (typically about 100 nanoseconds) it is said to "gain switch" the particular transition, in much the same way Q-switching a laser oscillator produces short duration pulses.
Resonant pumping for the purpose of generating mid-infrared wavelengths from activator ions in various hosts has often been employed in the prior art. For example, in the invention disclosed in U.S. Pat. No. 5,200,966 to Esterowitcz and Stoneman, the 4I11/2 upper laser state of the erbium ion was directly pumped with a pump beam at a wavelength of about 970 nm, causing the erbium ion to produce laser emission at substantially 2.8 μm, corresponding to the 4I11/2→4I15/2 laser transition, with high efficiency at room temperature. Because high power diode laser arrays with wavelengths in the 950-980 nm range have recently become more available, there have been several successful efforts demonstrating diode pumped, power scalable cw operation from Er-doped lasers. However, pulsed operation has been more elusive at or near 3 μm, even under seemingly favorable resonant pumping conditions. In another example, U.S. Pat. No. 4,330,763 to Esterowitcz and Kruer taught use of resonant pumping from a laser source at 2.06 μm to achieve inversion on the 7F3→7F5 line at 4.1 μm from terbium-doped YLF. A large ratio of non-radiative to radiative decay rates in this gain material discriminates against broad-band pumping, but allows the use of resonant, narrow-band excitation to produce laser action.
Heretofore, Holmium-doped lasers have also been made which are capable of pulsed operation in the infrared region of the spectrum upon resonant pumping by radiation from Nd:YAG lasers with output near 1 μm. In particular, pulsed emission at or near 3 μm from Ho-doped garnets such as YAG, GGG and YALO was described wherein co-doping with suitable activator ion such as praseodymium (Pr) was utilized to allow resonant pumping near 1 μm. For example, Anton in U.S. Pat. No. 5,070,507 describes a laser system wherein a Nd-doped laser operating on a non-standard line of 1.123 μm is used to pump holmium laser to produce a moderately high energy output pulse at about 3 μm. Key to the invention by Anton was the incorporation of holmium ion with concentrations in excess of 15% (atomic percent) and a much lower praseodymium (Pr) concentration (on the order of 0.01%). The higher Ho concentration allowed preferential lasing on the 2.94 μm line in Ho-doped garnet crystals upon pumping with the 1.12 μm output of a Nd:YAG laser, whereas the Pr ion served to quench the lifetime of the lower 5I7 laser level, thereby breaking the bottleneck of the normally self-terminating 5I5→5I6 transition.
In the early demonstrations of the long wavelength transitions in Ho3+-doped YLF using resonant pumping of the 5S2 manifold with short pulse green lasers, laser action on the 3.9 μm line was achieved as part of a sequence with other transitions, a process known in the art as cascade lasing. Specifically, using a frequency-doubled short pulse (20 ns) Nd:glass laser operating at 535 nm to pump a 1% Ho:YLF crystal, the two-line 5S2→5I5, 5I5→5I6(1.392 μm, 3.914 μm) and 5S2→5I5, 5I5→5I7 (1.392 μm, 1.673 μm) cascade transitions were successfully lased at room temperature (see L. Esterowitz, R. C. Eckardt and R. E. Allen, Appl. Phys. Lett., 35,236, (1979)). Three-step laser transitions, for example at 3.4 μm, 3.9 μm and 2.9 μm were also reported (see R. C. Eckart, L. Esterowitz and Y. P. Lee, Procs. Int'l Conf. Lasers, pp. 380 (1981)) in Ho:YLF using the longer 1 μs pulse from a pulsed dye laser tuned to 535.5 nm. These and similar results were further described in U.S. Pat. No. 4,321,559 to Esterowitz and Eckardt. A key feature in these early descriptions of resonantly pumped cascade lasing was that cascade processes, whereby one laser transition sequentially pumps a lower laser transition in the same material, could be viewed as one form of resonant self-pumping. By causing population inversion to occur sequentially, cascade laser action can therefore improve the efficiency of laser transitions between intermediate manifolds, as well as produce radiation consisting of two or more wavelengths. In the case of short pulse green laser excitation of the high lying 5S2 state, cavity optics can be selected to preferentially lase a given sequence of transitions. For example, by using one set of coated optics, the excited 5S2 state population could be directly transferred to the intermediate 5I5 level, which then serves as the upper level for a subsequent 3.9 μm laser transition to the 5I6 level. A different set of cavity mirrors cause the second lasing step to occur on the 1.7 μm 5I5→5I7 line.
Yet, although prior art describing the advantages of resonant pumping and multi-wavelengths cascade lasing was related nearly two decades ago, to date no practical Ho-doped laser has been constructed with one output wavelength near either the 2.9μ or 3.9 μm lines, using principles taught by Esterowitcz and Eckardt. One problem with prior art systems based on resonant pumping is that they require a laser with a wavelength tuned closely to an appropriate absorption band of the laser material. For example, in the case the Ho ion, lasing at 3.9 μm was previously obtained only as part of a sequence of cascade transitions, by resonantly pumping the 5I8 ground state to the 5S2, 5F4 level. To increase the pumping efficiency, the green beam had to be tuned close to the appropriate absorption peak, which in fluorides is near 535 nm. This wavelength matches up poorly with most readily available commercial lasers, which is one of the factors precluding practical application of such cascade lasers to date. Similarly, the methods and system disclosed by Anthon for generating 2.9 μm radiation from Ho-doped garnets, while recognizing the benefits to improved efficiencies that could be obtained by increasing holmium concentrations, still required a pump laser tuned to 1.1 μm, which is a difficult wavelength to obtain from a practical laser system, especially if short pulse operation is desired as well. Thus, even if pump lasers with wavelengths suitable for pumping holmium could be constructed, other conditions on the pulse duration, energy, repetition rate, and beam quality may place additional limitations on practical implementations of the infrared laser system with the output power, output wavelengths and efficiency desired.
It is therefore one object of the present invention to disclose a means for achieving efficient room temperature laser operation at 3.9 μm from a holmium-doped fluoride crystal pumped by a practical pulsed source tuned to a resonance, and with pulse duration short enough to allow population inversion between the upper 5I5 level and the long lived 5I6 lower laser level.
It is another object of the invention to disclose a pulsed Ho-doped laser operatively configured as a 2.9 μm or 3.9 μm downconverter for a shorter wavelength laser that is available as a commercial source. Examples of such sources include the 532 nm from frequency-doubled Nd:YAG, Nd:Vanadate, or other Nd-doped systems a Ti:sapphire or Cr:LiSAF laser tuned to about 890 nm, a fosterite or fiber Raman laser operating near 1.2 μm.
It is an additional object to be able to efficiently accomplish said downconversion utilizing short pulse (nanosecond) pump lasers, thereby gain switching the transitions near 2.9 and/or 3.9 μm so as to produce short pulses at these infrared wavelengths.
It is still another object to generate one or more different wavelengths in the infrared between 750 nm and 4 μm, but specifically including the wavelengths near 2.9 and/or 3.9 μm, utilizing resonant pumping of a holmium-doped fluoride crystal with a shorter wavelength pump laser.
It is a further object to provide a method and system for generating said output wavelengths alone or in a cascade with other infrared wavelengths at output energies scalable to over 10 millijoules and with repetition rates scalable to over 10 Hz.
It is yet another object to disclose methods for generating energy scalable longer infrared wavelengths at room temperature using a resonant pump source with pulse duration that is sufficiently long to enable efficient pumping even from end-pumped configurations. It is therefore a special object to be able to operate the pump laser at energy densities that are well above the threshold for sustained laser oscillation while staying below damage thresholds to sensitive IR coatings. In various embodiments of the invention such pump sources may include free running, or long pulse tunable Cr:LiSAF or Ti:sapphire lasers, frequency-doubled Nd-doped lasers, Raman fiber lasers and high power, quasi-cw semiconductor laser arrays.
In accordance with the above objectives, system and method is disclosed for generating at least one long infrared wavelength from a holmium-doped fluoride laser source pumped by a resonant pulsed narrow-band source. The invention includes pump sources with short enough pulse durations to gain switch a particular transition and also pump sources with long pulses but sufficiently high energy dsensity to overcome the saturation density associated with the transition. Of particular importance to the present invention are techniques for selecting the holmium concentration so as to optimize absorption at a wavelength that is available as a practical commercial laser source. In preferred embodimets of the invention the particular wavelengths of 3.9 μm and 2.9 μm are generated alone or in sequence with each other or with other wavelengths including but not limited to 1.4 μm, 2.4 μm and 2.0 μm. Pump wavelengths include 532 nm, such as is available from stanfdard Nd-doped lasers, 890 nm from Cr:LiSAF, Ti:sapphire, or diode laser arrays and 1.2 μm from, for example fosterite or Raman fiber lasers.
Further objects and advantages of this invention will be apparent from the following detailed description of a presently preferred embodiment, which is illustrated schematically in the accompanying drawings.
Before explaining the disclosed embodiment of the present invention in detail it is to be understood that the invention is not limited in its application to the details of the particular arrangement shown since the invention is capable of other embodiments. Also, the terminology used herein is for the purpose of description and not of limitation.
As earlier noted and to which now should be referenced,
For the purpose of validating the salient features of the present invention, key spectroscopic and dynamic characteristics were determined for both Ho:BYF and Ho:YLF crystals, at several concentrations between 1% and 20% (atomic percent). All the crystals were grown using a conventional Czochralski technique from purified starting materials. Crystals with the general properties described herein can be acquired commercially, for example, from AC materials, Inc.
As a key element of the invention, higher concentrations of the active Ho ion are used principally to increase the absorption strength and to also extend the absorption bandwidth, thereby allowing effective excitation off the peak of the absorption curve. The absorption at 532 nm was measured for both Ho:YLF and Ho:BYF at several concentrations. For Ho:YLF it was found to range from 0.6 cm-1 for a 1% concentration sample to 5.6 cm-1 in the 20% sample. The trend is similar for Ho:BYF. An absorption spectrum for the 10% Ho:BYF sample used in subsequent experiments is shown in
It is further noted that time resolved fluorescence decay measurements of other intermediate levels in Ho:BYF revealed no significant lifetime quenching of either the 5I6 or 5I7 levels and only slight effect on the lifetime of the 5I5 level (less than 10% decrease) even for 20% Ho concentrations. Therefore the dynamic behavior of the 3.9 μm laser transition should directly reflect the behavior of the preceding transition from 5S2. The weak dependence of the intermediate 5I6 and 5I7 level lifetimes on the holmium concentration is similar to that referenced in the prior art invention to Anton (U.S. Pat. No. 5,070,507) for holmium-doped garnets such as YAG and GGG, except that the corresponding lifetimes in fluorides are generally higher. However, although use of high concentration Ho for the purpose of increasing absorption of a pump source was taught by Anton, this was done only in reference to pumping the 5I6 level with a Nd:YAG laser modified to emit near 1.1 μm, and demonstrating laser action on the 2.9 μm line by relying on energy transfer to a co-dopant such as Pr3+ to suppress the 5I7 lifetime and achieve inversion. More specifically, the measurements by Anton showed that incorporation of low concentrations of Pr could be used to eliminate self termination of the 5I6→5I7 transition near 3 μm in Ho-doped garnets. It was not however realized by Anton that higher concentrations of Ho can also have the very beneficial use of enhancing absorption to a preferred level and allowing access to practical wavelengths available from standard commercial sources. Neither was it understood by Anton that by taking advantage of cascade transitions, further flexibility in selecting and tuning the pump wavelength can be realized, thereby giving rise to a multiplicity of wavelengths that can all be generated from a single Ho-doped material. It should be further pointed out that the present invention does not rely on a co-dopant, as the preferred embodiment employs pulsed pumping with short pulse durations which circumvent self-termination of the transitions of interest, including those shown in
Referring now to
Lasing at 1.4 μm for the foregoing example was readily achieved with a low threshold of less than 1 mJ absorbed pump energy. Threshold for cascade lasing at 3.9 μm was reached at approximately 5 mJ of absorbed (10 mJ incident) pump energy at 532 μm.
These results are remarkable, given that the laser cavity of
The principal limitation of the laser of
Many alternative designs of the 532 nm pumped 3.9 μm laser and/or 1.4 μm laser are possible, and fall under the scope of the present invention. These include alternative output coupling optics, using for example a dichroic prism to separate the two output wavelengths and side pumped configurations based on cavity designs that are known in the art. Although the preferred embodiment is described by reference to a frequency-doubled Nd:YAG as the pump laser, this should not be construed as limiting the domain of applicability of the invention. In particular, a number of other pulsed green laser sources can be advantageousely utilized to provide the pump radiation, including, but not limited to, frequency-doubled Nd:YALO and Nd:YVO4. Further increases in the Ho concentration to beyond 20% are also feasible, and will likely result in still greater absorption. There is however a trade-off against the 5S2 lifetime which places an upper limit on desirable Ho concentration for a given pump pulse duration, and such trade-offs should be taken into account in designing a practical laser system based on high concentration Ho doped fluoride materials.
While the cascade process depicted in
In a preferred embodiment corresponding to the scheme depicted in
As long as the repetition rate is smaller than the inverse of the lower state lifetime, lasting conditions can be realized such that the upper laser level is directly and continuousely populated to achieve and maintain inversion throughout the pump pulse duration.
Thereby achieving and maintaining inversion throughout the pump pulse duration. In this manner of operation, stimulated emission can be created and sustained even from levels lacking sufficiently long fluorescence lifetimes relative to a lower laser level. These are important considerations for situations when long pulse pumping is desired as a way to lower the incident peak power thereby reducing the risk of optical damage to coatings. Peak power damage thresholds are known to be smaller for mid-infrared coatings and damage can become an especially significant issue in end-pumped configurations, where sensitive dichroic coatings are typically employed. On the other hand, longer pump pulse durations reduce the available peak power, so the long pulse pump source must be capable of delivering enough energy per pulse to overcome the threshold as (as defined by saturation power density) by at least a factor of 5 to 10, thus sustaining laser operation. Since saturation power density is inversely proportional to the level lifetime, and the 5I6 lifetime is relatively short--only about 40 μs in 10% Ho:BYF--the saturation power density for the 5I5→5I6 transition is estimated to be as high as 100 kW/cm2. Therefore narrow-band pumping with a long (10's of microseconds) pulse require a source scalable to correspondingly high energies. Flashlamp-pumped Cr:liSAF is one such source, as it can deliver well over 0.5 J with a beam quality that is good enough to allow focusing to small spot, thus achieving the requisite power densities within the gain material.
In alternative embodiments of the system of
While the invention has been described, discosed, illustrated and shown in various terms of certain embodiments or modifications which it has presumed in practice, the scope of the invention is not intended to be, nor should it be deemed to be, limited thereby and such other modifications or embodiments as may be suggested by the teachings herein are particularly reserved especially as they fall within the breadth and scope of the claims here appended.
Jenssen, Hans P., Tabirian, Anna M., Buchter, Scott, Hoffman, Hanna J.
Patent | Priority | Assignee | Title |
10004402, | Sep 03 2002 | OMNI CONTINUUM, LLC | Measurement apparatus for physiological parameters |
10041832, | Nov 18 2005 | OMNI CONTINUUM, LLC | Mid-infrared super-continuum laser |
10098546, | Jan 21 2013 | Omni Medsci, Inc. | Wearable devices using near-infrared light sources |
10105059, | Dec 31 2012 | Omni Medsci, Inc. | System configured for measuring physiological parameters |
10126283, | Dec 31 2012 | Omni Medsci, Inc. | Near-infrared time-of-flight imaging |
10136819, | Dec 31 2012 | Omni Medsci, Inc. | Short-wave infrared super-continuum lasers and similar light sources for imaging applications |
10172523, | Dec 31 2012 | Omni Medsci, Inc. | Light-based spectroscopy with improved signal-to-noise ratio |
10188299, | Dec 31 2012 | Omni Medsci, Inc. | System configured for measuring physiological parameters |
10201283, | Dec 31 2012 | Omni Medsci, Inc. | Near-infrared laser diodes used in imaging applications |
10213113, | Dec 31 2012 | Omni Medsci, Inc. | Physiological measurement device using light emitting diodes |
10271904, | Jan 07 2010 | OMNI CONTINUUM, LLC | Laser-based method and system for selectively processing target tissue material in a patient and optical catheter assembly for use therein |
10386230, | Dec 31 2012 | Omni Medsci, Inc. | Near-infrared time-of-flight remote sensing |
10441176, | Dec 31 2012 | Omni Medsci, Inc. | Imaging using near-infrared laser diodes with distributed bragg reflectors |
10466102, | Nov 18 2005 | OMNI CONTINUUM, LLC | Spectroscopy system with laser and pulsed output beam |
10517484, | Dec 31 2012 | OMNI MEDSCI, INC | Semiconductor diodes-based physiological measurement device with improved signal-to-noise ratio |
10660526, | Dec 31 2012 | Omni Medsci, Inc.; OMNI MEDSCI, INC | Near-infrared time-of-flight imaging using laser diodes with Bragg reflectors |
10677774, | Dec 31 2012 | OMNI MEDSCI, INC | Near-infrared time-of-flight cameras and imaging |
10820807, | Dec 31 2012 | Omni Medsci, Inc. | Time-of-flight measurement of skin or blood using array of laser diodes with Bragg reflectors |
10874304, | Dec 31 2012 | Omni Medsci, Inc. | Semiconductor source based near infrared measurement device with improved signal-to-noise ratio |
10918287, | Dec 31 2012 | Omni Medsci, Inc. | System for non-invasive measurement using cameras and time of flight detection |
10928374, | Dec 31 2012 | Omni Medsci, Inc.; OMNI MEDSCI, INC | Non-invasive measurement of blood within the skin using array of laser diodes with Bragg reflectors and a camera system |
10942064, | Nov 18 2005 | OMNI CONTINUUM, LLC | Diagnostic system with broadband light source |
11109761, | Dec 31 2012 | Omni Medsci, Inc. | High signal-to-noise ratio light spectroscopy of tissue |
11160455, | Dec 31 2012 | Omni Medsci, Inc. | Multi-wavelength wearable device for non-invasive blood measurements in tissue |
11241156, | Dec 31 2012 | Omni Medsci, Inc.; OMNI MEDSCI, INC | Time-of-flight imaging and physiological measurements |
11353440, | Dec 31 2012 | Omni Medsci, Inc. | Time-of-flight physiological measurements and cloud services |
6714346, | Mar 13 2003 | Jefferson Science Associates, LLC | Method and apparatus for THz radiation power enhancement |
7115514, | Oct 02 2003 | Coherent, Inc | Semiconductor manufacturing using optical ablation |
7139116, | Nov 30 2005 | Coherent, Inc | Post amplification optical isolator |
7143769, | Aug 11 2003 | Coherent, Inc | Controlling pulse energy of an optical amplifier by controlling pump diode current |
7245419, | Sep 22 2005 | Coherent, Inc | Wavelength-stabilized pump diodes for pumping gain media in an ultrashort pulsed laser system |
7259906, | Sep 03 2002 | OMNI CONTINUUM, LLC | System and method for voice control of medical devices |
7308171, | Nov 16 2005 | Coherent, Inc | Method and apparatus for optical isolation in high power fiber-optic systems |
7349452, | Dec 13 2004 | Coherent, Inc | Bragg fibers in systems for the generation of high peak power light |
7352790, | Jan 21 2005 | Northrop Grumman Systems Corporation | Method and apparatus for producing an eye-safe laser |
7361171, | May 20 2003 | Coherent, Inc | Man-portable optical ablation system |
7367969, | Aug 11 2003 | Coherent, Inc | Ablative material removal with a preset removal rate or volume or depth |
7413847, | Feb 09 2004 | Coherent, Inc | Semiconductor-type processing for solid-state lasers |
7433116, | Sep 03 2002 | OMNI CONTINUUM, LLC | Infra-red light source including a raman shifter |
7436866, | Nov 30 2005 | Coherent, Inc | Combination optical isolator and pulse compressor |
7633673, | Mar 30 2004 | OMNI CONTINUUM, LLC | System and method for generating infrared light for use in medical procedures |
8055108, | Nov 18 2005 | OMNI CONTINUUM, LLC | Broadband or mid-infrared fiber light sources |
8098423, | Sep 03 2002 | OMNI MEDSCI, INC | System and method for voice control of medical devices |
8125704, | Aug 18 2008 | Coherent, Inc | Systems and methods for controlling a pulsed laser by combining laser signals |
8135050, | Jul 19 2005 | Coherent, Inc | Automated polarization correction |
8139910, | Jan 23 2006 | Coherent, Inc | Systems and methods for control of ultra short pulse amplification |
8150271, | Mar 28 2006 | Coherent, Inc | Active tuning of temporal dispersion in an ultrashort pulse laser system |
8173929, | Aug 11 2003 | Coherent, Inc | Methods and systems for trimming circuits |
8189971, | Jan 23 2006 | Coherent, Inc | Dispersion compensation in a chirped pulse amplification system |
8232687, | Apr 26 2006 | Coherent, Inc | Intelligent laser interlock system |
8391660, | Nov 18 2005 | OMNI MEDSCI, INC | Broadband or mid-infrared fiber light sources |
8398622, | May 20 2003 | Coherent, Inc | Portable optical ablation system |
8472108, | Sep 03 2002 | OMNI MEDSCI, INC | System and method for voice control of medical devices |
8619357, | Nov 30 2007 | Coherent, Inc | Static phase mask for high-order spectral phase control in a hybrid chirped pulse amplifier system |
8670642, | Nov 18 2005 | OMNI MEDSCI, INC | Broadband or mid-infrared fiber light sources |
8679011, | Sep 03 2002 | OMNI MEDSCI, INC | System and method for voice control of medical devices |
8757292, | Aug 20 2008 | Foro Energy, Inc. | Methods for enhancing the efficiency of creating a borehole using high power laser systems |
8848282, | Sep 03 2002 | OMNI MEDSCI, INC | System and method for voice control of medical devices |
8921733, | Aug 11 2003 | Coherent, Inc | Methods and systems for trimming circuits |
8971681, | Nov 18 2005 | OMNI CONTINUUM, LLC | Broadband or mid-infrared fiber light sources |
8997894, | Aug 20 2008 | Foro Energy, Inc. | Method and apparatus for delivering high power laser energy over long distances |
9022037, | Aug 11 2003 | Coherent, Inc | Laser ablation method and apparatus having a feedback loop and control unit |
9055868, | Sep 03 2002 | CHEETAH OMNI LLC | System and method for voice control of medical devices |
9066736, | Jan 07 2010 | OMNI CONTINUUM, LLC | Laser-based method and system for selectively processing target tissue material in a patient and optical catheter assembly for use therein |
9077146, | Nov 18 2005 | Omni Medsci, Inc. | Broadband or mid-infrared fiber light sources |
9120181, | Sep 16 2010 | Coherent, Inc | Singulation of layered materials using selectively variable laser output |
9130344, | Jan 23 2006 | Coherent, Inc | Automated laser tuning |
9164032, | Dec 31 2012 | Omni Medsci, Inc.; OMNI MEDSCI, INC | Short-wave infrared super-continuum lasers for detecting counterfeit or illicit drugs and pharmaceutical process control |
9281653, | Apr 26 2006 | Coherent, Inc | Intelligent laser interlock system |
9400215, | Nov 18 2005 | Omni Medsci, Inc. | Broadband or mid-infrared fiber light sources |
9456750, | Sep 03 2002 | Omni Medsci, Inc. | System and method for voice control of medical devices |
9456751, | Sep 03 2002 | Omni Medsci, Inc. | System and method for voice control of medical devices |
9476769, | Nov 18 2005 | OMNI CONTINUUM, LLC | Broadband or mid-infrared fiber light sources |
9494567, | Dec 31 2012 | OMNI MEDSCI, INC | Near-infrared lasers for non-invasive monitoring of glucose, ketones, HBA1C, and other blood constituents |
9500634, | Dec 31 2012 | OMNI MEDSCI, INC | Short-wave infrared super-continuum lasers for natural gas leak detection, exploration, and other active remote sensing applications |
9500635, | Dec 31 2012 | OMNI MEDSCI, INC | Short-wave infrared super-continuum lasers for early detection of dental caries |
9651533, | Dec 31 2012 | Omni Medsci, Inc. | Short-wave infrared super-continuum lasers for detecting counterfeit or illicit drugs and pharmaceutical process control |
9726539, | Nov 18 2005 | Omni Medsci, Inc. | Broadband or mid-infrared fiber light sources |
9757040, | Dec 31 2012 | Omni Medsci, Inc. | Short-wave infrared super-continuum lasers for early detection of dental caries |
9770174, | Sep 03 2002 | Omni Medsci, Inc. | System and method for voice control of measurement apparatus |
9797876, | Dec 31 2012 | Omni Medsci, Inc. | Short-wave infrared super-continuum lasers for natural gas leak detection, exploration, and other active remote sensing applications |
9861286, | Dec 31 2012 | Omni Medsci, Inc. | Short-wave infrared super-continuum lasers for early detection of dental caries |
9885698, | Dec 31 2012 | Omni Medsci, Inc. | Near-infrared lasers for non-invasive monitoring of glucose, ketones, HbA1C, and other blood constituents |
9897584, | Dec 31 2012 | Omni Medsci, Inc. | Short-wave infrared super-continuum lasers for natural gas leak detection, exploration, and other active remote sensing applications |
9993159, | Dec 31 2012 | Omni Medsci, Inc.; OMNI MEDSCI, INC | Near-infrared super-continuum lasers for early detection of breast and other cancers |
9995722, | Dec 31 2012 | Omni Medsci, Inc. | Short-wave infrared super-continuum lasers for natural gas leak detection, exploration, and other active remote sensing applications |
Patent | Priority | Assignee | Title |
4110702, | Nov 24 1976 | Sanders Associates, Inc. | Deep red laser |
4136316, | Jan 19 1977 | Sanders Associates, Inc. | Multi-color, activator-activator laser |
4321559, | Apr 03 1980 | The United States of America as represented by the Secretary of the Navy | Multiwavelength self-pumped solid state laser |
4330763, | Mar 19 1980 | The United States of America as represented by the Secretary of the Navy | Resonantly pumped mid-ir laser |
4917084, | Jul 31 1985 | CARDIOFOCUS, INC | Infrared laser catheter system |
4950266, | Jul 03 1985 | CARDIOFOCUS, INC | Infrared laser catheter system |
5070507, | Mar 02 1990 | Cisco Technology, Inc | Three micron laser |
5196004, | Jul 31 1985 | CARDIOFOCUS, INC | Infrared laser catheter system |
5200966, | May 14 1992 | DEPARTMENT OF THE NAVY | Resonantly pumped, erbium-doped, GSGG, 2.8 micron, solid state laser with energy recycling and high slope efficiency |
5313477, | Oct 30 1992 | The United States of America as represented by the Secretary of the Navy; UNITED STATES OF AMERICA ,THE, AS REPRESENTED BY THE SECRETARY OF THE NAVY | Rare earth ion doped CW cascade fiber laser |
5684815, | Jun 06 1995 | Central Glass Company, Limited | Upconversion laser material |
5742632, | Sep 07 1995 | NATIONAL AERONAUTICS AND SPACE ADMINISTRATION NASA , THE | Ho:LuLF and Ho:Tm:LuLF laser materials |
5843073, | Jul 13 1985 | CARDIOFOCUS, INC | Infrared laser catheter system |
6015765, | Dec 24 1997 | UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY, THE | Rare earth soluble telluride glasses |
6269108, | May 26 1999 | University of Central Florida | Multi-wavelengths infrared laser |
20020031151, |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
May 22 2001 | University of Central Florida | (assignment on the face of the patent) | / |
Date | Maintenance Fee Events |
Dec 06 2006 | REM: Maintenance Fee Reminder Mailed. |
May 10 2007 | LTOS: Pat Holder Claims Small Entity Status. |
May 10 2007 | M2551: Payment of Maintenance Fee, 4th Yr, Small Entity. |
May 10 2007 | M2554: Surcharge for late Payment, Small Entity. |
Nov 19 2010 | M2552: Payment of Maintenance Fee, 8th Yr, Small Entity. |
Nov 13 2014 | M2553: Payment of Maintenance Fee, 12th Yr, Small Entity. |
Date | Maintenance Schedule |
May 20 2006 | 4 years fee payment window open |
Nov 20 2006 | 6 months grace period start (w surcharge) |
May 20 2007 | patent expiry (for year 4) |
May 20 2009 | 2 years to revive unintentionally abandoned end. (for year 4) |
May 20 2010 | 8 years fee payment window open |
Nov 20 2010 | 6 months grace period start (w surcharge) |
May 20 2011 | patent expiry (for year 8) |
May 20 2013 | 2 years to revive unintentionally abandoned end. (for year 8) |
May 20 2014 | 12 years fee payment window open |
Nov 20 2014 | 6 months grace period start (w surcharge) |
May 20 2015 | patent expiry (for year 12) |
May 20 2017 | 2 years to revive unintentionally abandoned end. (for year 12) |